Source: BioSpace

International Genetically Engineered Machine Foundation: Twist Bioscience Continues Support for Next Generation of Synthetic Biologists Through Work with iGEM Competition

Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced its continued partnership with the International Genetically Engineered Machine (iGEM) Foundation.

Read full article »
Est. Annual Revenue
$100K-5.0M
Est. Employees
25-100
CEO Avatar

CEO

Update CEO

CEO Approval Rating

- -/100

Read more